Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-18 Sale | 2021-06-22 4:44 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 48,493 | $60.11 | $2,914,851 | 16,479 (Direct) | View |
| 2021-06-17 Sale | 2021-06-21 4:18 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 2,502 | $60.02 | $150,170 | 17,372 (Direct) | View |
| 2021-06-09 Sale | 2021-06-11 5:00 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 28,002 | $60.09 | $1,682,554 | 45,114 (Direct) | View |
| 2021-06-07 Sale | 2021-06-09 4:06 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 10,943 | $60.05 | $657,171 | 86,940 (Direct) | View |
| 2021-04-19 Sale | 2021-04-21 5:11 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 17,611 | $55.12 | $970,636 | 71,332 (Direct) | View |
| 2020-05-20 Sale | 2020-05-21 5:05 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 3,583 | $50.01 | $179,200 | 24,029 (Direct) | View |
| 2020-02-13 Sale | 2020-02-18 4:05 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 7,100 | $50.16 | $356,112 | 20,956 (Direct) | View |
| 2020-02-11 Sale | 2020-02-13 4:21 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 621 | $50.02 | $31,063 | 28,056 (Direct) | View |
| 2020-02-04 Sale | 2020-02-06 4:52 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 49,638 | $50.08 | $2,485,989 | 91,151 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-09-12 9:11 pm | N/A 2034-08-06 | Bicara Therapeutics Inc. | BCAX | Bowden Christopher Director | 0 | $0 | 59,501 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:31 pm | N/A 2032-06-21 | Alaunos Therapeutics Inc. | TCRT | Bowden Christopher Director | 140,000 | $0 | 144,167 (Direct) | View |
| 2021-06-18 Exercise | 2021-06-22 4:44 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 46,608 | $50.4 | 16,479 (Direct) | View |
| 2021-06-18 Exercise | 2021-06-22 4:44 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 1,885 | $39.76 | 16,479 (Direct) | View |
| 2021-06-18 Exercise | 2021-06-22 4:44 pm | N/A 2026-02-15 | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 48,493 | $0 | 16,479 (Direct) | View |
| 2021-06-17 Exercise | 2021-06-21 4:18 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 2,502 | $39.76 | 17,372 (Direct) | View |
| 2021-06-17 Exercise | 2021-06-21 4:18 pm | N/A 2026-02-15 | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 2,502 | $0 | 17,372 (Direct) | View |
| 2021-06-09 Exercise | 2021-06-11 5:00 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 28,002 | $39.76 | 45,114 (Direct) | View |
| 2021-06-09 Exercise | 2021-06-11 5:00 pm | N/A 2026-02-15 | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 28,002 | $0 | 45,114 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-09 4:06 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 10,943 | $39.76 | 86,940 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-09 4:06 pm | N/A 2026-02-15 | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 10,943 | $0 | 86,940 (Direct) | View |
| 2021-03-04 Option Award | 2021-05-06 7:20 pm | N/A 2031-03-03 | ZIOPHARM ONCOLOGY INC | ZIOP | Bowden Christopher Director | 35,417 | $0 | 35,417 (Direct) | View |
| 2021-04-19 Exercise | 2021-04-21 5:11 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 15,723 | $35.16 | 71,332 (Direct) | View |
| 2021-04-20 Exercise | 2021-04-21 5:11 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 1,888 | $39.76 | 71,332 (Direct) | View |
| 2021-04-19 Exercise | 2021-04-21 5:11 pm | N/A 2024-05-30 | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 17,611 | $0 | 71,332 (Direct) | View |
| 2021-02-24 Tax Withholding | 2021-02-24 4:11 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 986 | $0 | 18,743 (Direct) | View |
| 2021-02-22 Exercise | 2021-02-24 4:11 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 3,334 | $0 | 18,743 (Direct) | View |
| 2021-02-16 Tax Withholding | 2021-02-17 4:14 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 2,069 | $0 | 21,062 (Direct) | View |
| 2021-02-14 Exercise | 2021-02-17 4:14 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 6,750 | $0 | 21,062 (Direct) | View |
| 2021-02-10 Option Award | 2021-02-12 4:22 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-05-21 Option Award | 2020-05-22 5:09 pm | N/A 2030-05-20 | MIRAGEN THERAPEUTICS INC. | MGEN | Bowden Christopher Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2020-05-20 Exercise | 2020-05-21 5:05 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 3,583 | $35.16 | 24,029 (Direct) | View |
| 2020-05-20 Exercise | 2020-05-21 5:05 pm | N/A 2024-05-30 | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 3,583 | $0 | 24,029 (Direct) | View |
| 2020-04-14 Tax Withholding | 2020-04-15 4:25 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 2,368 | $40.64 | 18,791 (Direct) | View |
| 2020-04-13 Exercise | 2020-04-15 4:25 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 5,280 | $0 | 18,791 (Direct) | View |
| 2020-02-24 Tax Withholding | 2020-02-25 4:26 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 1,596 | $48.66 | 11,985 (Direct) | View |
| 2020-02-22 Exercise | 2020-02-25 4:26 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 3,333 | $0 | 11,985 (Direct) | View |
| 2020-02-18 Tax Withholding | 2020-02-19 4:53 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 819 | $52.01 | 63,331 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:53 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 57,000 | $0 | 63,331 (Direct) | View |
| 2020-02-16 Exercise | 2020-02-19 4:53 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 2,750 | $0 | 63,331 (Direct) | View |
| 2020-02-13 Exercise | 2020-02-18 4:05 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 7,100 | $35.16 | 20,956 (Direct) | View |
| 2020-02-13 Exercise | 2020-02-18 4:05 pm | N/A 2024-05-30 | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 7,100 | $0 | 20,956 (Direct) | View |
| 2020-02-11 Exercise | 2020-02-13 4:21 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 621 | $35.16 | 28,056 (Direct) | View |
| 2020-02-11 Exercise | 2020-02-13 4:21 pm | N/A 2024-05-30 | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 621 | $0 | 28,056 (Direct) | View |
| 2020-02-04 Exercise | 2020-02-06 4:52 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 43,973 | $35.16 | 91,151 (Direct) | View |
| 2020-02-04 Exercise | 2020-02-06 4:52 pm | N/A 2024-05-30 | AGIOS PHARMACEUTICALS INC. | AGIO | Bowden Christopher Chief Medical Officer | 43,973 | $0 | 91,151 (Direct) | View |
| 2019-12-31 Option Award | 2020-01-03 5:02 pm | N/A 2029-12-31 | ZIOPHARM ONCOLOGY INC | ZIOP | Bowden Christopher Director | 50,562 | $0 | 50,562 (Direct) | View |